Clinical Trials Browser

OTHER × Anti-Bacterial Agents × Plasma cell × Clear all

NCT01042704 2017-07-31

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

Phase 1 Completed

Neoplasms, Plasma Cell